Literature DB >> 33499374

TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish.

Maria-Letizia Campanari1, Anca Marian1, Sorana Ciura1, Edor Kabashi1.   

Abstract

The "distal axonopathy" hypothesis in amyotrophic lateral sclerosis (ALS) proposes that pathological changes occur at the neuromuscular junction (NMJ) early in the disease. While acetylcholinesterase (AChE) plays an important role in the functionality of the NMJ, its potential role in ALS remains unexplored. Here, we identified AChE as a limiting factor regulating muscle/motor neuron connection in a vertebrate model of ALS. Knockdown of the TAR DNA-binding protein 43 (TDP-43) orthologue in zebrafish resulted in early defects of motor functions coupled with NMJ disassembly. We found that a partially depleted tdp-43 caused a decrease of ache expression. Importantly, human AChE overexpression reduced the phenotypic defects in the tdp-43 loss of function model, with amelioration of post- and pre-synaptic deficits at the NMJ. In conclusion, our results provide a better understanding of the role of TDP-43 in the NMJ organization and indicate AChE as a contributing factor in the pathology of ALS. In particular, it may be implicated in the early defects that characterize NMJs in this major neurodegenerative disorder.

Entities:  

Keywords:  TAR DNA-binding protein 43 (TDP-43); acetylcholinesterase (AChE); amyotrophic lateral sclerosis (ALS); knockdown (KD); neuromuscular junction (NMJ)

Year:  2021        PMID: 33499374      PMCID: PMC7911940          DOI: 10.3390/cells10020221

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  81 in total

Review 1.  Neurobiology of butyrylcholinesterase.

Authors:  Sultan Darvesh; David A Hopkins; Changiz Geula
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

2.  Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.

Authors:  Eleonora Palma; Jorge Mauricio Reyes-Ruiz; Diego Lopergolo; Cristina Roseti; Cristina Bertollini; Gabriele Ruffolo; Pierangelo Cifelli; Emanuela Onesti; Cristina Limatola; Ricardo Miledi; Maurizio Inghilleri
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

3.  Neuromuscular transmission in amyotrophic lateral sclerosis.

Authors:  R A Maselli; R L Wollman; C Leung; B Distad; S Palombi; D P Richman; E F Salazar-Grueso; R P Roos
Journal:  Muscle Nerve       Date:  1993-11       Impact factor: 3.217

Review 4.  TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Ian Ra Mackenzie; Rosa Rademakers; Manuela Neumann
Journal:  Lancet Neurol       Date:  2010-10       Impact factor: 44.182

5.  MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.

Authors:  Andrew H Williams; Gregorio Valdez; Viviana Moresi; Xiaoxia Qi; John McAnally; Jeffrey L Elliott; Rhonda Bassel-Duby; Joshua R Sanes; Eric N Olson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

6.  Acetylcholinesterase function is dispensable for sensory neurite growth but is critical for neuromuscular synapse stability.

Authors:  Gerald B Downes; Michael Granato
Journal:  Dev Biol       Date:  2004-06-01       Impact factor: 3.582

7.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Paul N Valdmanis; Patrick Dion; Dan Spiegelman; Brendan J McConkey; Christine Vande Velde; Jean-Pierre Bouchard; Lucette Lacomblez; Ksenia Pochigaeva; Francois Salachas; Pierre-Francois Pradat; William Camu; Vincent Meininger; Nicolas Dupre; Guy A Rouleau
Journal:  Nat Genet       Date:  2008-03-30       Impact factor: 38.330

8.  Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis.

Authors:  Sorana Ciura; Serena Lattante; Isabelle Le Ber; Morwena Latouche; Hervé Tostivint; Alexis Brice; Edor Kabashi
Journal:  Ann Neurol       Date:  2013-08       Impact factor: 10.422

9.  Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish.

Authors:  Robin Lemmens; Annelies Van Hoecke; Nicole Hersmus; Veerle Geelen; Isabel D'Hollander; Vincent Thijs; Ludo Van Den Bosch; Peter Carmeliet; Wim Robberecht
Journal:  Hum Mol Genet       Date:  2007-07-17       Impact factor: 6.150

10.  TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle.

Authors:  Thomas O Vogler; Joshua R Wheeler; Eric D Nguyen; Michael P Hughes; Kyla A Britson; Evan Lester; Bhalchandra Rao; Nicole Dalla Betta; Oscar N Whitney; Theodore E Ewachiw; Edward Gomes; James Shorter; Thomas E Lloyd; David S Eisenberg; J Paul Taylor; Aaron M Johnson; Bradley B Olwin; Roy Parker
Journal:  Nature       Date:  2018-10-31       Impact factor: 49.962

View more
  4 in total

Review 1.  Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Sagar Verma; Shiffali Khurana; Abhishek Vats; Bandana Sahu; Nirmal Kumar Ganguly; Pradip Chakraborti; Mandaville Gourie-Devi; Vibha Taneja
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

Review 2.  Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases.

Authors:  Jenny L Carey; Lin Guo
Journal:  Front Mol Biosci       Date:  2022-02-02

3.  Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases.

Authors:  Léa Lescouzères; Benoît Bordignon; Pascale Bomont
Journal:  Front Mol Neurosci       Date:  2022-09-20       Impact factor: 6.261

Review 4.  Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.

Authors:  Xiaobo Wang; Jin-Bao Zhang; Kai-Jie He; Fen Wang; Chun-Feng Liu
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.